Author

Gary Gene Chiang

eFFECTOR Therapeutics (United States)ORCID 0000-0003-3004-7400Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander Edward Dela Cruz DriloniD· 1 shared Corina AmoriD· 1 shared Douglas Warner· 1 shared Elisa de StanchinaiD· 1 shared Ezra Y. RoseniD· 1 shared Fresia G. ParejaiD· 1 shared Guangli YangiD· 1 shared Hans‐Guido WendeliD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander Edward Dela Cruz DrilonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedJul 21, 2025

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

Jacob A. Boyer, Ezra Y. Rosen, Malvika Sharma…·Neal X. Rosen

This paper identifies eIF4A as a key regulator of ER translation in breast cancer and shows that inhibiting eIF4A, either alone or with fulvestrant, suppresses ER expression and tumor growth in advanced ER+ breast cancer.

16 citationstop 1%

humanproteomics

𝕏 PostBluesky